[HTML][HTML] Costs of multimorbidity: a systematic review and meta-analyses
PB Tran, J Kazibwe, GF Nikolaidis, I Linnosmaa… - BMC medicine, 2022 - Springer
Background Multimorbidity is a rising global phenomenon, placing strains on countries'
population health and finances. This systematic review provides insight into the costs of …
population health and finances. This systematic review provides insight into the costs of …
A methodology to assess the population size and estimate the needed resources for new licensed medications by combining clinical and administrative databases …
F Lapi, E Bianchini, E Marconi, G Medea… - … and Drug Safety, 2023 - Wiley Online Library
Purpose To develop and validate a model to estimate glycated haemoglobin (HbA1c) values
in patients with type 2 diabetes mellitus (T2DM) using a clinical data source, with the aim to …
in patients with type 2 diabetes mellitus (T2DM) using a clinical data source, with the aim to …
[HTML][HTML] Major Adverse Cardiovascular Events in Coronary Type 2 Diabetic Patients: Identification of Associated Factors Using Electronic Health Records and Natural …
C González-Juanatey, M Anguita-Sánchez… - Journal of clinical …, 2022 - mdpi.com
Patients with Type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD) are at
high risk of developing major adverse cardiovascular events (MACE). This is a multicenter …
high risk of developing major adverse cardiovascular events (MACE). This is a multicenter …
[HTML][HTML] Effects of intermittent compared with continuous energy restriction on blood pressure control in overweight and obese patients with hypertension
CJ He, YP Fei, CY Zhu, M Yao, G Qian… - Frontiers in …, 2021 - frontiersin.org
Background and Aims: Weight-loss diets reduce body weight and improve blood pressure
control in hypertensive patients. Intermittent energy restriction (IER) is an alternative to …
control in hypertensive patients. Intermittent energy restriction (IER) is an alternative to …
[HTML][HTML] Impact of Advanced Age on the Incidence of Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stable Coronary Artery …
C González-Juanatey, M Anguita-Sánchez… - Journal of Clinical …, 2023 - mdpi.com
Patients with type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD) without
myocardial infarction (MI) or stroke are at high risk for major cardiovascular events (MACEs) …
myocardial infarction (MI) or stroke are at high risk for major cardiovascular events (MACEs) …
[PDF][PDF] Major Adverse Cardiovascular Events in Coronary Type 2 Diabetic Patients: Identification of Associated Factors Using Electronic Health Records and Natural …
M Anguita-Sánchez, T Soriano Colomé, IJ Nuñez Gil… - 2022 - scientiasalut.gencat.cat
Patients with Type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD) are at
high risk of developing major adverse cardiovascular events (MACE). This is a multicenter …
high risk of developing major adverse cardiovascular events (MACE). This is a multicenter …